Erin E. Tapper

Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD Promoter.

R. Diasio, Q. Nie, R. Wu, 2016, Cancer research.

Targeting Cancer-Associated Fibroblasts in the Bone Marrow Prevents Resistance to CART-Cell Therapy in Multiple Myeloma.

N. Kay, D. Jelinek, Yi Lin, 2022, Blood.

Leukemic Extracellular Vesicles Induce Chimeric Antigen Receptor T Cell Dysfunction in Chronic Lymphocytic Leukemia.

Yohan Kim, E. Braggio, N. Kay, 2020, Molecular therapy : the journal of the American Society of Gene Therapy.

GM-CSF disruption in CART cells modulates T cell activation and enhances CART cell anti-tumor activity

N. Kay, S. Sinha, M. Adada, 2022, Leukemia.

Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity

Aditya Bansal, M. Pandey, T. DeGrado, 2021, Cancer Immunology Research.

Targeting Cancer Associated Fibroblasts in the Bone Marrow Prevents Resistance to Chimeric Antigen Receptor T Cell Therapy in Multiple Myeloma

N. Kay, S. Parikh, R. Sakemura, 2019, Biology of Blood and Marrow Transplantation.

Dose modification for safe treatment of a compound complex heterozygous DPYD variant carrier with 5-fluorouracil.

R. Diasio, T. Hobday, E. Tapper, 2018, JCO precision oncology.